LHV establishes an EUR 1,000,000,000 Covered Bond Programme
May 20, 2020 01:00 ET
|
AS LHV Group
AS LHV Pank ("LHV") has established an EUR 1,000,000,000 Covered Bond Programme ("Programme"). The Central Bank of Ireland has approved the base prospectus ("Base Prospectus") for the Programme on 19...
Hexagon Composites ASA: Results for the first quarter of 2020
May 20, 2020 01:00 ET
|
Hexagon Composites ASA
In the first quarter of 2020, Hexagon Group generated NOK 825 (822) million in revenues and recorded an operating profit before depreciation (EBITDA) of NOK 37 (150) million. This was driven by solid...
Schibsted ASA (SCHA/SCHB) – Mandatory notification of trade: Employee Share Saving Plan and long-term incentive plans
May 20, 2020 01:00 ET
|
Schibsted
Schibsted ASA has on 19 May 2020 sold 22,130 treasury B-shares to participants in the Employee Share Saving Plan. The shares will be transferred to the participants in the coming days. 7,714...
Outcome of Annual General Meeting of May 19, 2020
May 20, 2020 01:00 ET
|
INNATE PHARMA
Pascale Boissel appointed new member of Innate’s Supervisory Board Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) announces the results of...
Santhera Completes Enrollment of Phase 3 SIDEROS Study with Puldysa® (Idebenone) in Duchenne Muscular Dystrophy (DMD)
May 20, 2020 01:00 ET
|
Santhera Pharmaceuticals Holding AG
Pratteln, Switzerland, May 20, 2020 – Santhera Pharmaceuticals (SIX: SANN) announces full recruitment of its Phase 3 SIDEROS study with idebenone in Duchenne muscular dystrophy (DMD). The sample-size...
2020 First-Quarter Business
May 20, 2020 01:00 ET
|
PARROT
PRESS RELEASEParis, May 20, 2020, 7am CET 2020 FIRST-QUARTER BUSINESS Business for the first quarter of 2020 reflects the context of the spread of the health and economic crisis in Europe and a...
Adevinta (ADE) - Share buyback
May 20, 2020 01:00 ET
|
Adevinta ASA
Oslo, 20 May 2020 – Adevinta ASA has on 19 May 2020 purchased 50,000 own shares at an average price of NOK 99.6908 per share. After this, Adevinta ASA owns a total of 220,000 own shares. The purchase...
Addex Reports Q1 2020 Financial Results and Provides Corporate Update
May 20, 2020 01:00 ET
|
Addex Therapeutics
Geneva, Switzerland, May 20, 2020 – Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development,...
Central Bank of Savings Banks Finland Plc: S&P Global Ratings has revised the outlook on Central Bank of Savings Banks Finland Plc from stable to negative
May 20, 2020 01:00 ET
|
Central Bank of Savings Banks Finland Plc
Central Bank of Savings Banks Finland Plc Stock Exchange Release20 May 2020 at 8.00 On May 19th 2020, S&P Global Ratings has revised the outlook on Central Bank of Savings Banks...
Outcome Of Annual General Meeting Of May 19, 2020
May 20, 2020 01:00 ET
|
INNATE PHARMA
MARSEILLE, France, May 20, 2020 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) announces the results of the vote of its...